Pharmaceutical Metrics

Author: David S. Zuckerman
Editor: Routledge
ISBN: 1351911546
File Size: 72,26 MB
Format: PDF, ePub, Docs
Read: 2969
Download

'What gets measured gets fixed' and this is as true of the pharmaceutical industry as any other. The problem is that pharmaceutical businesses are complex. Drug research and development involves extended and expensive processes; defining appropriate metrics for these processes is not easy, yet ineffective or misguided metrics can be more damaging than none at all. David Zuckerman's Pharmaceutical Metrics is an extremely practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results. And because metrics are about how to shape and develop your business, he explores how to deploy them organization-wide and make sure that they are driving business improvement. In order to reflect the needs of different types of pharmaceutical company the author uses four sample companies, throughout the book, to illustrate the principles for 'big pharma', 'micro pharma', a virtual development company and a CRO. This highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R&D, supported by case studies of the techniques applied and tips for optimizing the system.

Pharmaceutical Metrics

Author: David S. Zuckerman
Editor: Routledge
ISBN: 1351911538
File Size: 18,10 MB
Format: PDF, ePub
Read: 717
Download

'What gets measured gets fixed' and this is as true of the pharmaceutical industry as any other. The problem is that pharmaceutical businesses are complex. Drug research and development involves extended and expensive processes; defining appropriate metrics for these processes is not easy, yet ineffective or misguided metrics can be more damaging than none at all. David Zuckerman's Pharmaceutical Metrics is an extremely practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results. And because metrics are about how to shape and develop your business, he explores how to deploy them organization-wide and make sure that they are driving business improvement. In order to reflect the needs of different types of pharmaceutical company the author uses four sample companies, throughout the book, to illustrate the principles for 'big pharma', 'micro pharma', a virtual development company and a CRO. This highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R&D, supported by case studies of the techniques applied and tips for optimizing the system.

Parexel S Pharmaceutical R D Statistical Sourcebook

Author:
Editor:
ISBN:
File Size: 76,27 MB
Format: PDF, ePub, Mobi
Read: 9503
Download


Pharmaceutical Metrics

Author: David S. Zuckerman
Editor:
ISBN: 9781315246932
File Size: 33,18 MB
Format: PDF, ePub
Read: 8308
Download


Brands And Their Companies

Author:
Editor:
ISBN: 9780787633233
File Size: 58,71 MB
Format: PDF, Docs
Read: 220
Download


Brands And Their Companies

Author: Linda D. Hall
Editor:
ISBN: 9780787670573
File Size: 14,57 MB
Format: PDF, ePub, Mobi
Read: 8599
Download


Pharmaceutical Operations Management

Author: Pankaj Mohan
Editor: McGraw Hill Professional
ISBN: 0071712089
File Size: 39,62 MB
Format: PDF, ePub
Read: 8862
Download

This book brings together a winning team of international operations experts to set the framework for building a world-class manufacturing organization. Pharmaceutical Operations Management focuses on key concepts such as: Policy Execution, Risk Management, Supply chain modeling, Advance process control and Six Sigma for the pharmaceutical industry: critical techniques which will offset cost, increase efficiency and turn any manufacture into financial winner.

Size Metrics And Dynamics Of Firms Expansion In The European Pharmaceutical Industry

Author: Franco Mariuzzo
Editor:
ISBN:
File Size: 80,60 MB
Format: PDF, ePub
Read: 7885
Download

We generalize the growth-of-firm literature by linking alternative metrics of size via a Copula approach. We look at the result of the fitted Copula and justify the metric we base our analysis upon. We employ the Amadeus dataset and investigate the growth dynamics of the European pharmaceutical industry in the Single Market Programme era, 1990-2004. Relying on a set of dynamic panel Probit methods that deal with unobserved heterogeneity and initial conditions, we analyze how our units of investigation, multinationals, capture opportunities over time. We find strong evidence of state dependence and mean reversion, as predicated by the theory of maturation -- firms face a period of rapid growth, followed by a slow down, or even a stop, in growth. We finish off our exercise by conditioning the fitted Copula on the predicted measure of size and simulate the remaining measures.

Journal Of The American Pharmaceutical Association

Author:
Editor:
ISBN:
File Size: 77,19 MB
Format: PDF, Kindle
Read: 3516
Download


Handbook Of Pharmaceutical Biotechnology

Author: Shayne C. Gad
Editor: Wiley-Interscience
ISBN:
File Size: 26,14 MB
Format: PDF, ePub, Mobi
Read: 6683
Download

Describes the use of biotechnology to develop pharmaceuticals. This book gives the professional a basic tool to facilitate the development of biotech medicines by bringing together a general overview of biotechnology used in the drug development process, along with a compendium of regulations and validation methods.

Physicians Adoption Of Pharmaceutical E Detailing

Author: Fadi Alkhateeb
Editor: LAP Lambert Academic Publishing
ISBN: 9783838399973
File Size: 79,10 MB
Format: PDF, Mobi
Read: 432
Download

Fadi Alkhateeb is considered one of few experts who specialize in Pharmaceutical E-Marketing field. Dr. Alkhateeb currently works as Assistant Professor of Pharmaceutical Marketing in University of Charleston School of Pharmacy/USA. Dr. Alkhateeb believes that understanding each segment's needs and preferences is key to determining the right approach to e- detailing and offering the information and services that a particular segment values most. In this book, Dr. Alkhateeb explains key factors that influence physicians' adoption of e-detailing (Age, gender, years of practice, specialty, attitudes, academic affiliation, volume of prescription, gifts as incentive, practice setting size, peer influence, and relative advantage). Moreover, this book will demonstrate how to maximize the impact of eDetailing on the sales process and how to effectively target the right physician audience and finally this book explores physician perceptions and attitudes toward e-detailing, as well as behaviors related to e-detailing use among physicians like frequency, length of e-detailing use and the extent of physicians' involvement in e- detailing.

Science

Author:
Editor:
ISBN:
File Size: 65,28 MB
Format: PDF, ePub, Mobi
Read: 267
Download


Pharmaceutical Manufacturing

Author:
Editor:
ISBN:
File Size: 47,80 MB
Format: PDF, Docs
Read: 7269
Download


Proceedings Of Annual Meeting

Author: American Drug Manufacturers Association
Editor:
ISBN:
File Size: 16,89 MB
Format: PDF
Read: 2020
Download


Proceedings Of Annual Meeting Of National Association Of Manufacturers Of Medicinal Products

Author: American Drug Manufacturers Association. Meeting
Editor:
ISBN:
File Size: 65,70 MB
Format: PDF, ePub, Mobi
Read: 3238
Download


Journal Of The American Pharmaceutical Association

Author: American Pharmaceutical Association
Editor:
ISBN:
File Size: 67,12 MB
Format: PDF, Kindle
Read: 3298
Download


A Practical Approach To Pharmaceutical Policy

Author: Andreas Seiter
Editor: World Bank Publications
ISBN:
File Size: 54,65 MB
Format: PDF, ePub, Docs
Read: 9992
Download

Abundant literature is available on the spectrum of issues relevant to pharmaceutical policy---including regulation, pricing, financing, reimbursement, procurement, and distribution. What has been lacking is a practitioner's guide for navigating this complex field while considering the various challenges and limitations that characterize political reality. This book meets that need. There is no "one-size-fits-all" approach to pharmaceutical policy. Even two countries with similar objectives may need to apply different sets of policies, depending on their starting positions, preexisting laws and regulations, perceptions among providers and patients, and implementation capacity. Developed countries may find it hard to reconcile industrial policy and innovation with cost containment in the health sector. Middle-income countries may have to bridge the divide between a demanding urban population and large numbers of poor people in peri-urban and rural areas. Low-income countries may struggle to provide basic essential drugs to their populations through inefficient delivery systems that are still largely state run, while their growing private markets may be flooded with drugs of dubious origin and quality. In each case, policy makers and implementing agencies need to select and combine their policy measures in a way that not only conceptually addresses the main problems but also is practically viable and sustainable. A Practical Approach to Pharmaceutical Policy discusses the wide range of challenges facing policy makers, presents the current know-how, and provides specific examples of policy packages that can be used in defined circumstances. The book, which focuses on developing countries, equally addresses the issues faced by low-income and middle-income countries. It concludes with a prognosis of how things might evolve in the longer term, assuming convergence toward models that work to reduce the fragmentation of policies and enhance regulatory and economic efficiencies. Such an evolution to a sustainable platform would benefit all stakeholders, but particularly those who, as patients, do not have reliable access to effective and safe medicines. A Practical Approach to Pharmaceutical Policy will be of interest to pharmaceutical policy makers and advisers in developing countries; people in related fields such as health financing, health service delivery, and health insurance management; representatives of the pharmaceutical industry and associations; academics and students of public health policy, pharmacy, and health economics; and undergraduate and graduate students in related fields.